-
公开(公告)号:US20110152174A1
公开(公告)日:2011-06-23
申请号:US13022184
申请日:2011-02-07
CPC分类号: C12N9/52 , A61K38/1808 , A61K38/4886 , A61K47/64 , C07K16/1282 , C07K2319/00 , C12Y304/24069
摘要: The present invention relates to treatment of disease by inhibition of cellular secretory processes, to agents and compositions therefor, and to manufacture of those agents and compositions. The present invention relates particularly, to treatment of disease dependent upon the exocytotic activity of endocrine cells, exocrine cells, inflammatory cells, cells of the immune system, cells of the cardiovascular system and bone cells.
摘要翻译: 本发明涉及通过抑制细胞分泌过程,其药剂及其组合物治疗疾病,以及制备这些药剂和组合物。 本发明特别涉及依赖于内分泌细胞,外分泌细胞,炎症细胞,免疫系统细胞,心血管系统细胞和骨细胞的胞吐活性的疾病的治疗。
-
公开(公告)号:US20120101027A1
公开(公告)日:2012-04-26
申请号:US13344776
申请日:2012-01-06
CPC分类号: C12N9/52 , A61K38/1808 , A61K38/4886 , A61K47/48246 , A61K47/64 , C07K16/1282 , C07K2319/00 , C12Y304/24069
摘要: The present invention relates to treatment of disease by inhibition of cellular secretory processes, to agents and compositions therefor, and to manufacture of those agents and compositions. The present invention relates particularly, to treatment of disease dependent upon the exocytotic activity of endocrine cells, exocrine cells, inflammatory cells, cells of the immune system, cells of the cardiovascular system and bone cells.
摘要翻译: 本发明涉及通过抑制细胞分泌过程,其药剂及其组合物治疗疾病,以及制备这些药剂和组合物。 本发明特别涉及依赖于内分泌细胞,外分泌细胞,炎症细胞,免疫系统细胞,心血管系统细胞和骨细胞的胞吐活性的疾病的治疗。
-